InsiderTrades.com logo
Blackrock’s Sending THIS Crypto Higher on Purpose
From Crypto 101 Media   |   Ad
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
YES, I WANT THE #1 CRYPTO NOW

ENTA Insider Trading

Insider Ownership Percentage: 13.64%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $504,129.74

Enanta Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Enanta Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Enanta Pharmaceuticals Share Price & Price History

Current Price: $9.16
Price Change: ▲ Price Increase of +0.08 (0.88%)
As of 11/21/2024 03:45 PM ET

This chart shows the closing price history over time for ENTA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Trump’s Sending THIS Crypto Higher on Purpose
From Crypto 101 Media   |   Ad
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
YES, I WANT THE #1 CRYPTO NOW

Enanta Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/15/2024Scott T RottinghausInsiderSell5,375$17.08$91,805.0021,717View SEC Filing Icon  
7/11/2024Scott T RottinghausInsiderSell4,299$15.07$64,785.9323,988View SEC Filing Icon  
6/17/2024Tara Lynn KiefferInsiderSell7,266$12.33$89,589.7832,341View SEC Filing Icon  
12/13/2023Terry VanceDirectorSell15,295$9.12$139,490.405,800View SEC Filing Icon  
12/5/2023Brendan LuuVPSell2,125$9.63$20,463.7536,736View SEC Filing Icon  
12/5/2023Jay R. LulyCEOSell7,230$9.63$69,624.90806,793View SEC Filing Icon  
12/5/2023Paul J MellettCFOSell2,412$9.63$23,227.5693,549View SEC Filing Icon  
12/5/2023Scott T RottinghausCMOSell534$9.63$5,142.4226,466View SEC Filing Icon  
3/15/2023Paul J MellettCFOSell10,440$44.43$463,849.2097,556View SEC Filing Icon  
3/15/2023Yat Sun OrVPSell13,925$44.45$618,966.25374,702View SEC Filing Icon  
3/13/2023Jay R. LulyCEOSell27,912$45.16$1,260,505.92819,810View SEC Filing Icon  
2/9/2023Paul J MellettCFOSell5,000$53.76$268,800.0083,463View SEC Filing Icon  
12/16/2022Jay R. LulyCEOSell30,000$44.72$1,341,600.00773,805View SEC Filing Icon  
4/4/2022Nathalie AddaVPSell32,785$72.18$2,366,421.3034,982View SEC Filing Icon  
4/1/2022Nathalie AddaVPSell50,559$71.23$3,601,317.5734,982View SEC Filing Icon  
3/21/2022Bruce L A CarterDirectorSell6,000$67.83$406,980.00View SEC Filing Icon  
3/1/2022Nathalie AddaVPSell24,339$70.26$1,710,058.14View SEC Filing Icon  
1/11/2022Nathalie AddaVPSell12,536$70.13$879,149.68View SEC Filing Icon  
12/1/2021Nathalie AddaVPSell13,523$86.35$1,167,711.05View SEC Filing Icon  
See Full Table
Trump’s Sending THIS Crypto Higher on Purpose
From Crypto 101 Media   |   Ad
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
YES, I WANT THE #1 CRYPTO NOW

SEC Filings (Institutional Ownership Changes) for Enanta Pharmaceuticals (NASDAQ:ENTA)

94.99% of Enanta Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ENTA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Enanta Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC27,438$0.29M0.0%+294.2%0.129%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC477,351$4.95M0.0%+3.1%2.253%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC27,438$0.29M0.0%+294.2%0.129%Search for SEC Filing on Google Icon
11/15/2024Krensavage Asset Management LLC1,498,074$15.52M8.7%+19.7%7.070%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC23,176$0.24M0.0%-19.2%0.109%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP34,751$0.36M0.0%N/A0.164%Search for SEC Filing on Google Icon
11/15/2024State Street Corp449,975$4.66M0.0%+6.4%2.124%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.87,190$0.90M0.0%N/A0.411%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.191,726$1.99M0.0%-1.5%0.905%Search for SEC Filing on Google Icon
11/15/2024Erste Asset Management GmbH120,000$1.24M0.0%N/A0.566%Search for SEC Filing on Google Icon
11/14/2024Caligan Partners LP322,453$3.34M1.1%-69.1%1.522%Search for SEC Filing on Google Icon
11/14/2024PDT Partners LLC33,342$0.35M0.0%-8.0%0.157%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC43,899$0.46M0.0%+96.4%0.207%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC170,615$1.77M0.0%-13.9%0.805%Search for SEC Filing on Google Icon
11/13/2024FMR LLC49,301$0.51M0.0%+18.9%0.233%Search for SEC Filing on Google Icon
11/12/2024Valence8 US LP19,939$0.21M0.1%N/A0.094%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.162,398$1.68M0.0%-1.0%0.766%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.11,768$0.12M0.0%N/A0.056%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC19,123$0.20M0.0%+65.0%0.090%Search for SEC Filing on Google Icon
10/28/2024US Bancorp DE4,329$45K0.0%+4,933.7%0.020%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.143,806$1.49M0.0%-66.3%0.679%Search for SEC Filing on Google Icon
9/16/2024Cubist Systematic Strategies LLC45,350$0.59M0.0%+65.8%0.214%Search for SEC Filing on Google Icon
9/16/2024Point72 Asia Singapore Pte. Ltd.14,326$0.19M0.0%-43.2%0.068%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC683,143$8.86M0.0%-3.3%3.226%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC60,005$0.78M0.0%-45.3%0.283%Search for SEC Filing on Google Icon
8/15/2024Armistice Capital LLC1,096,000$14.22M0.2%-11.3%5.175%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.14,326$0.19M0.0%-43.2%0.068%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC45,350$0.59M0.0%+65.8%0.214%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP928,363$12.04M0.0%-2.4%4.383%Search for SEC Filing on Google Icon
8/13/2024Sei Investments Co.72,925$0.95M0.0%-17.3%0.344%Search for SEC Filing on Google Icon
8/12/2024Hsbc Holdings PLC18,086$0.23M0.0%-11.3%0.085%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC510,900$6.63M0.0%-2.9%2.412%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP129,062$1.67M0.0%-31.8%0.609%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.27,892$0.36M0.0%+35.4%0.132%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC11,588$0.15M0.0%+511.2%0.055%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC849,424$11.01M0.0%-0.5%4.011%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers34,566$0.45M0.0%+4.7%0.163%Search for SEC Filing on Google Icon
7/26/2024Allspring Global Investments Holdings LLC2,667$35K0.0%N/A0.013%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp73,841$0.96M0.0%+13.3%0.349%Search for SEC Filing on Google Icon
7/18/2024Assenagon Asset Management S.A.426,561$5.53M0.0%-26.9%2.014%Search for SEC Filing on Google Icon
5/24/2024Farallon Capital Management LLC2,095,000$36.58M0.2%+3.5%9.891%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC10,927$0.19M0.0%N/A0.052%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System2,037$36K0.0%-38.1%0.010%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.194,730$3.40M0.0%-65.3%0.919%Search for SEC Filing on Google Icon
5/15/2024Public Employees Retirement System of Ohio7,662$0.13M0.0%-76.3%0.036%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC853,896$14.91M0.1%+1.3%4.036%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,928,078$33.66M0.0%+7.5%9.114%Search for SEC Filing on Google Icon
5/9/2024State Board of Administration of Florida Retirement System6,781$0.12M0.0%N/A0.032%Search for SEC Filing on Google Icon
5/9/2024Portland Global Advisors LLC24,375$0.43M0.1%-28.7%0.115%Search for SEC Filing on Google Icon
5/8/2024Russell Investments Group Ltd.19,213$0.34M0.0%-19.9%0.091%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC7,574$0.13M0.0%-25.5%0.036%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets24,683$0.43M0.0%-50.1%0.117%Search for SEC Filing on Google Icon
4/17/2024Hennion & Walsh Asset Management Inc.13,689$0.24M0.0%-13.1%0.065%Search for SEC Filing on Google Icon
2/14/2024Pennant Investors LP35,100$0.33M0.1%N/A0.166%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC2,064,000$19.42M0.3%-1.7%9.754%Search for SEC Filing on Google Icon
2/9/2024Quest Partners LLC15,465$0.15M0.0%N/A0.073%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP118,612$1.12M0.0%-10.5%0.561%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC31,868$0.30M0.0%-43.7%0.151%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets49,459$0.47M0.0%-10.8%0.234%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund7,772$73K0.0%-23.1%0.037%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.133,189$1.25M0.0%N/A0.629%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio18,700$0.18M0.0%+20.6%0.089%Search for SEC Filing on Google Icon
1/25/2024Nisa Investment Advisors LLC2,827$27K0.0%+417.8%0.013%Search for SEC Filing on Google Icon
1/17/2024Assenagon Asset Management S.A.583,658$5.49M0.0%-7.6%2.771%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC10,162$96K0.0%-45.2%0.048%Search for SEC Filing on Google Icon
1/8/2024Diversified Trust Co16,900$0.16M0.0%N/A0.080%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.1,660,520$18.55M0.0%-2.7%7.885%Search for SEC Filing on Google Icon
11/21/2023Walleye Capital LLC119,364$1.33M0.0%+342.8%0.567%Search for SEC Filing on Google Icon
11/17/2023Jacobs Levy Equity Management Inc.345,651$3.86M0.0%-0.5%1.641%Search for SEC Filing on Google Icon
11/15/2023Krensavage Asset Management LLC735,103$8.21M3.0%+6.9%3.491%Search for SEC Filing on Google Icon
11/15/2023Laurion Capital Management LP11,287$0.13M0.0%N/A0.054%Search for SEC Filing on Google Icon
11/15/2023Armistice Capital LLC2,100,000$23.46M0.4%+3.1%9.972%Search for SEC Filing on Google Icon
11/14/2023Caxton Associates LP18,028$0.20M0.0%N/A0.086%Search for SEC Filing on Google Icon
11/14/2023Sherbrooke Park Advisers LLC10,100$0.11M0.0%N/A0.048%Search for SEC Filing on Google Icon
11/14/2023Trexquant Investment LP132,561$1.48M0.0%N/A0.629%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC548,782$6.13M0.0%+445.6%2.606%Search for SEC Filing on Google Icon
11/13/2023Clearstead Advisors LLC5,064$57K0.0%N/A0.024%Search for SEC Filing on Google Icon
11/8/2023Janney Montgomery Scott LLC62,452$0.70M0.0%N/A0.297%Search for SEC Filing on Google Icon
11/7/2023Virtus ETF Advisers LLC12,784$0.14M0.1%-11.5%0.061%Search for SEC Filing on Google Icon
11/7/2023Quantbot Technologies LP7,200$80K0.0%+2,300.0%0.034%Search for SEC Filing on Google Icon
11/7/2023Clearstead Advisors LLC5,064$57K0.0%N/A0.024%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC17,219$0.19M0.0%-66.2%0.082%Search for SEC Filing on Google Icon
11/7/2023Jump Financial LLC56,636$0.63M0.0%+41.5%0.269%Search for SEC Filing on Google Icon
11/6/2023Assenagon Asset Management S.A.631,626$7.06M0.0%+613.6%2.999%Search for SEC Filing on Google Icon
10/27/2023Hennion & Walsh Asset Management Inc.28,034$0.31M0.0%-7.8%0.133%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp107,955$1.21M0.0%-34.9%0.513%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC18,546$0.21M0.0%-68.9%0.088%Search for SEC Filing on Google Icon
10/10/2023Daymark Wealth Partners LLC10,000$0.11M0.0%N/A0.047%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC50,904$1.09M0.0%+93.9%0.242%Search for SEC Filing on Google Icon
8/11/2023Krensavage Asset Management LLC687,613$14.72M4.7%+14.0%3.265%Search for SEC Filing on Google Icon
8/10/2023Profund Advisors LLC17,594$0.38M0.0%+65.9%0.084%Search for SEC Filing on Google Icon
8/9/2023BNP Paribas Arbitrage SNC46,853$1M0.0%+102.3%0.222%Search for SEC Filing on Google Icon
8/9/2023Commonwealth of Pennsylvania Public School Empls Retrmt SYS22,372$0.48M0.0%+7.6%0.106%Search for SEC Filing on Google Icon
8/8/2023Rhumbline Advisers64,744$1.39M0.0%+1.4%0.307%Search for SEC Filing on Google Icon
8/7/2023Principal Financial Group Inc.115,487$2.47M0.0%-5.0%0.548%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC100,581$2.15M0.0%N/A0.478%Search for SEC Filing on Google Icon
8/3/2023Barclays PLC50,904$1.09M0.0%+93.9%0.242%Search for SEC Filing on Google Icon
8/3/2023Bank of New York Mellon Corp165,793$3.55M0.0%-1.1%0.787%Search for SEC Filing on Google Icon
7/31/2023Strs Ohio15,500$0.33M0.0%+8.4%0.074%Search for SEC Filing on Google Icon
7/31/2023Inspire Investing LLC14,743$0.32M0.0%+118.4%0.070%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Enanta Pharmaceuticals logo
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. The company has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. Enanta Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
Read More on Enanta Pharmaceuticals

Today's Range

Now: $9.16
Low: $8.75
High: $9.42

50 Day Range

MA: $11.20
Low: $9.08
High: $13.00

52 Week Range

Now: $9.16
Low: $8.51
High: $17.80

Volume

177,786 shs

Average Volume

196,581 shs

Market Capitalization

$194.10 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.56

Who are the company insiders with the largest holdings of Enanta Pharmaceuticals?

Enanta Pharmaceuticals' top insider shareholders include:
  1. Jay R Luly (CEO)
  2. Yat Sun Or (VP)
  3. Paul J Mellett (CFO)
  4. Brendan Luu (VP)
  5. Tara Lynn Kieffer (Insider)
  6. Scott T Rottinghaus (CMO)
  7. Scott T Rottinghaus (Insider)
  8. Terry Vance (Director)
Learn More about top insider investors at Enanta Pharmaceuticals.

Who are the major institutional investors of Enanta Pharmaceuticals?

Enanta Pharmaceuticals' top institutional investors include:
  1. Krensavage Asset Management LLC — 7.07%
  2. Geode Capital Management LLC — 2.25%
  3. State Street Corp — 2.12%
  4. Caligan Partners LP — 1.52%
  5. Jacobs Levy Equity Management Inc. — 0.90%
  6. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.81%
Learn More about top institutional investors of Enanta Pharmaceuticals stock.

Which major investors are selling Enanta Pharmaceuticals stock?

During the last quarter, ENTA stock was sold by these institutional investors:
  1. Caligan Partners LP
  2. Assenagon Asset Management S.A.
  3. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  4. Jane Street Group LLC
  5. PDT Partners LLC
  6. Jacobs Levy Equity Management Inc.
  7. Charles Schwab Investment Management Inc.
In the last year, company insiders that have sold Enanta Pharmaceuticals company stock include:
  1. Jay R Luly (CEO)
  2. Yat Sun Or (VP)
  3. Paul J Mellett (CFO)
  4. Brendan Luu (VP)
  5. Tara Lynn Kieffer (Insider)
  6. Scott T Rottinghaus (CMO)
  7. Scott T Rottinghaus (Insider)
Learn More investors selling Enanta Pharmaceuticals stock.

Which major investors are buying Enanta Pharmaceuticals stock?

During the previous quarter, ENTA stock was bought by institutional investors including:
  1. Krensavage Asset Management LLC
  2. Erste Asset Management GmbH
  3. Point72 Asset Management L.P.
  4. Wellington Management Group LLP
  5. State Street Corp
  6. Walleye Capital LLC
  7. Barclays PLC
  8. Barclays PLC
Blackrock’s Sending THIS Crypto Higher on Purpose
From Crypto 101 Media   |   Ad
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
YES, I WANT THE #1 CRYPTO NOW